Revision of USP general chapter radiopharmaceuticals for positron emission tomography - Compounding 〈823〉

Joseph C. Hung; Sally W. Schwarz; Steve S. Zigler; Ravi Ravichandran

Revision of USP general chapter radiopharmaceuticals for positron emission tomography - Compounding 〈823〉

Joseph C. Hung, Sally W. Schwarz, Steve S. Zigler, Ravi Ravichandran

Division of Research Imaging Facilities

Research output: Contribution to journal › Review article › peer-review

Abstract

This Stimuli article presents the reasons for the proposed revision of General Chapter Radiopharmaceuticals for Positron Emission Tomography - Compounding 〈823〉 , as well as the basis for each of the major changes. The objectives of this Stimuli article are four-fold: (1) provide background about the need for the proposed revision, (2) offer rationale for each major change, (3) initiate discussion, and (4) solicit public comments that will be reviewed and considered by USP's Expert Committee.

Original language	English
Journal	Pharmacopeial Forum
Volume	37
Issue number	1
State	Published - 2011

Cite this

@article{38109faa180f4cbd952db302f9a048ee,

title = "Revision of USP general chapter radiopharmaceuticals for positron emission tomography - Compounding 〈823〉",

abstract = "This Stimuli article presents the reasons for the proposed revision of General Chapter Radiopharmaceuticals for Positron Emission Tomography - Compounding 〈823〉 , as well as the basis for each of the major changes. The objectives of this Stimuli article are four-fold: (1) provide background about the need for the proposed revision, (2) offer rationale for each major change, (3) initiate discussion, and (4) solicit public comments that will be reviewed and considered by USP's Expert Committee.",

author = "Hung, {Joseph C.} and Schwarz, {Sally W.} and Zigler, {Steve S.} and Ravi Ravichandran",

year = "2011",

language = "English",

volume = "37",

journal = "Pharmacopeial Forum",

issn = "0363-4655",

number = "1",

}

TY - JOUR

T1 - Revision of USP general chapter radiopharmaceuticals for positron emission tomography - Compounding 〈823〉

AU - Hung, Joseph C.

AU - Schwarz, Sally W.

AU - Zigler, Steve S.

AU - Ravichandran, Ravi

PY - 2011

Y1 - 2011

N2 - This Stimuli article presents the reasons for the proposed revision of General Chapter Radiopharmaceuticals for Positron Emission Tomography - Compounding 〈823〉 , as well as the basis for each of the major changes. The objectives of this Stimuli article are four-fold: (1) provide background about the need for the proposed revision, (2) offer rationale for each major change, (3) initiate discussion, and (4) solicit public comments that will be reviewed and considered by USP's Expert Committee.

AB - This Stimuli article presents the reasons for the proposed revision of General Chapter Radiopharmaceuticals for Positron Emission Tomography - Compounding 〈823〉 , as well as the basis for each of the major changes. The objectives of this Stimuli article are four-fold: (1) provide background about the need for the proposed revision, (2) offer rationale for each major change, (3) initiate discussion, and (4) solicit public comments that will be reviewed and considered by USP's Expert Committee.

UR - http://www.scopus.com/inward/record.url?scp=80053168500&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:80053168500

SN - 0363-4655

VL - 37

JO - Pharmacopeial Forum

JF - Pharmacopeial Forum

IS - 1

ER -

Revision of USP general chapter radiopharmaceuticals for positron emission tomography - Compounding 〈823〉

Abstract

Other files and links

Fingerprint

Cite this